Trial intelligence / Profile preview

Monocaprin denture adhesive/gel study for oral Candida infection

2012-005216-26Phase 2Completed

Sponsor
University of Iceland
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of monocaprin in oral candidiasis and denture stomatitis (DS) (3 arms), sponsored by University of Iceland. Primary endpoint: Change in oral yeast colony counts. Started Jan 2013; status: completed.

02

Drugs

monocaprin
03

Conditions

oral candidiasisdenture stomatitis (DS)

Beyond the preview

Go deeper on 2012-005216-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005216-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call